Literature DB >> 1418697

Protein calorie malnutrition and cancer therapy.

H L Parnes1, J Aisner.   

Abstract

Anorexia and cachexia frequently complicate the late stages of malignancy and may be a prominent feature of early disease. The resulting weight loss often becomes a major focus of concern for the patient and the family and may significantly add to the morbidity and mortality of cancer. Factors which contribute to the wasting syndrome include the effects of the tumour, effects of chemotherapy, abnormalities of carbohydrate, fat and protein metabolism and the cytokine response. Administration of total parenteral nutrition (TPN) is an important method of addressing malnutrition, particularly in patients with nonfunctioning gastrointestinal tracts. A critical review of the TPN cancer literature is provided along with a discussion of new approaches and future directions in the nutritional support of patients with malignant disease, such as anabolic agents, hydrazine sulfate and megestrol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418697     DOI: 10.2165/00002018-199207060-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  83 in total

1.  The potential of megestrol acetate in the treatment of cancer cachexia.

Authors:  H Parnes; N Tait; J Aisner
Journal:  Nutrition       Date:  1989 May-Jun       Impact factor: 4.008

Review 2.  Parenteral nutrition in the surgical patient.

Authors:  L K Shanbhogue; W J Chwals; M Weintraub; G L Blackburn; B R Bistrian
Journal:  Br J Surg       Date:  1987-03       Impact factor: 6.939

Review 3.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

4.  Correlation of tumor necrosis factor and prostaglandin E2 production of monocytes in bladder cancer patients.

Authors:  S Ikemoto; T Kishimoto; S Nishio; S Wada; M Maekawa
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

Review 5.  Fat metabolism and cancer.

Authors:  P F McAndrew
Journal:  Surg Clin North Am       Date:  1986-10       Impact factor: 2.741

6.  Cachexia of malignancy: potential role of insulin in nutritional management.

Authors:  P S Schein; D Kisner; D Haller; M Blecher; M Hamosh
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

7.  Parabiotic transfer of cancer anorexia/cachexia in male rats.

Authors:  J A Norton; J F Moley; M V Green; R E Carson; S D Morrison
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

8.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

9.  Megestrol acetate-induced differentiation of 3T3-L1 adipocytes in vitro.

Authors:  A W Hamburger; H Parnes; G B Gordon; L M Shantz; K A O'Donnell; J Aisner
Journal:  Semin Oncol       Date:  1988-04       Impact factor: 4.929

10.  A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.

Authors:  M B Popp; R I Fisher; R M Simon; M F Brennan
Journal:  Cancer Treat Rep       Date:  1981
View more
  2 in total

Review 1.  Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-05-19       Impact factor: 8.262

2.  Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.

Authors:  V Gebbia; A Testa; N Gebbia
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.